CELLULAR BIOMEDICINE GROUP
Cellular Biomedicine Group is a biomedicine firm engaged in the development of new treatments for degenerative and cancerous diseases utilizing proprietary cell therapy technologies. It is the result of the acquisition, transfer, commercialization, and advancement of thirty years of research and human treatment experience in cellular medicine. Its cellular research and development is the result of collaboration among scientists and doctors from the US, England, and China.
CELLULAR BIOMEDICINE GROUP
Industry:
Biotechnology Medical Device Therapeutics
Founded:
2009-01-01
Address:
Palo Alto, California, United States
Country:
United States
Website Url:
http://www.cellbiomedgroup.com
Total Employee:
101+
Status:
Active
Contact:
+1 650-566-5064
Email Addresses:
[email protected]
Total Funding:
203.64 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Domain Not Resolving Microsoft Azure DNS Facebook Sharer Twitter Tweet Button Alibaba
Similar Organizations
Accessbio
Access BIO is a consulting group focused on the development of drug, biologic, and medical device products.
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Checkmate Pharmaceuticals
Checkmate Pharma is a clinical stage biopharmaceutical company developing a new approach for cancer immunotherapy.
Monarch Mining
Monarch Mining is a fully integrated mining company that owns four advanced projects.
Proov
Proov offers the most advanced system for women to evaluate their hormones at home, built upon patented, FDA cleared medical devices.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2014-08-06 | Agreen Biotech | Agreen Biotech acquired by Cellular Biomedicine Group | 22 M USD |
Investors List
TF Capital
TF Capital investment in Series A - Cellular Biomedicine Group
YF Capital
YF Capital investment in Series A - Cellular Biomedicine Group
Sequoia Capital China
Sequoia Capital China investment in Series A - Cellular Biomedicine Group
GIC
GIC investment in Series A - Cellular Biomedicine Group
AstraZeneca
AstraZeneca investment in Series A - Cellular Biomedicine Group
Sailing Capital
Sailing Capital investment in Post-IPO Equity - Cellular Biomedicine Group
Wuhan Dangdai Science & Technology Industries Group
Wuhan Dangdai Science & Technology Industries Group investment in Post-IPO Equity - Cellular Biomedicine Group
Official Site Inspections
http://www.cellbiomedgroup.com
- Host name: 203.107.44.133
- IP address: 203.107.44.133
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
